FSD Pharma Inc. - Class B Subordinate Voting Shares (HUGE)
HUGE moved a median of 0.00% 30 minutes after news, and -1.71% by the close. How HUGE actually reacts to news — the realized, point-in-time move the market made, measured across 110 labeled events over the last three years with zero look-ahead.
HUGE’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 101 |
| 30-min | 0.00% | 44% | 104 |
| 60-min | +0.61% | 54% | 104 |
| to close | -1.71% | 36% | 105 |
| Middle 50% of HUGE reactions | -1.97% to +1.64% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 110 |
Half of all FSD Pharma Inc. - Class B Subordinate Voting Shares news events land between -1.97% and +1.64% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when HUGE moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to HUGE's baseline. Nothing else.
Recent HUGE events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update | Press release | Accesswire | — | — | |
| Form 6-K/A Quantum Biopharma Ltd. For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K Quantum Biopharma Ltd. For: Aug 15 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K FSD Pharma Inc. For: Aug 14 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K FSD Pharma Inc. For: Aug 13 | SEC filing · Form 6-K | SEC EDGAR | +4.21% | -5.37% | |
| Form 6-K/A FSD Pharma Inc. For: Aug 13 | SEC filing · Form 6-K | SEC EDGAR | +4.21% | -5.37% | |
| Form 6-K FSD Pharma Inc. For: Aug 10 | SEC filing · Form 6-K | SEC EDGAR | -6.67% | -38.14% | |
| Form 6-K FSD Pharma Inc. For: Aug 08 | SEC filing · Form 6-K | SEC EDGAR | -7.96% | +7.58% | |
| FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team | Press release | Accesswire | -7.96% | +7.58% | |
| Form 6-K FSD Pharma Inc. For: Jul 29 | SEC filing · Form 6-K | SEC EDGAR | -5.38% | -16.22% | |
| Form 6-K FSD Pharma Inc. For: Jul 08 | SEC filing · Form 6-K | SEC EDGAR | — | +3.88% | |
| Form 6-K FSD Pharma Inc. For: Jun 27 | SEC filing · Form 6-K | SEC EDGAR | -4.42% | -8.16% | |
| Form 6-K FSD Pharma Inc. For: Jun 28 | SEC filing · Form 6-K | SEC EDGAR | -1.38% | -14.38% | |
| FSD Pharma provides Corporate Update | Press release | Accesswire | -1.38% | -14.38% | |
| FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd. | Press release | Accesswire | -4.42% | -8.16% | |
| Form 6-K FSD Pharma Inc. For: Jun 26 | SEC filing · Form 6-K | SEC EDGAR | +1.72% | -2.30% | |
| FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia | Press release | Accesswire | +1.72% | -2.30% | |
| Form 6-K FSD Pharma Inc. For: Jun 12 | SEC filing · Form 6-K | SEC EDGAR | -1.44% | -6.48% | |
| FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications | Press release | Accesswire | -1.44% | -6.48% | |
| Form 6-K FSD Pharma Inc. For: Jun 03 | SEC filing · Form 6-K | SEC EDGAR | -0.72% | -0.29% | |
| FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication | Press release | Accesswire | -0.72% | -0.29% | |
| Form 6-K FSD Pharma Inc. For: May 30 | SEC filing · Form 6-K | SEC EDGAR | -6.67% | +0.00% | |
| FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest | Press release | Accesswire | -6.67% | +0.00% | |
| Form 6-K FSD Pharma Inc. For: May 28 | SEC filing · Form 6-K | SEC EDGAR | +5.07% | -1.71% | |
| FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication | Press release | Accesswire | +5.07% | -1.71% | |
| Form 6-K FSD Pharma Inc. For: May 24 | SEC filing · Form 6-K | SEC EDGAR | +5.07% | -1.71% | |
| FSD Pharma Provides Corporate Update | Press release | Accesswire | — | — | |
| Form 6-K FSD Pharma Inc. For: May 16 | SEC filing · Form 6-K | SEC EDGAR | -1.79% | -5.97% | |
| FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM) | Press release | Accesswire | -1.79% | -5.97% | |
| Form 6-K FSD Pharma Inc. For: May 14 | SEC filing · Form 6-K | SEC EDGAR | +1.16% | -5.92% | |
| Form 6-K FSD Pharma Inc. For: May 06 | SEC filing · Form 6-K | SEC EDGAR | -1.90% | -3.50% | |
| FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia | Press release | Accesswire | -1.90% | -3.50% | |
| Form 6-K FSD Pharma Inc. For: Apr 30 | SEC filing · Form 6-K | SEC EDGAR | -8.42% | -15.10% | |
| FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication | Press release | Accesswire | -8.42% | -15.10% | |
| Form 6-K FSD Pharma Inc. For: Apr 22 | SEC filing · Form 6-K | SEC EDGAR | -7.31% | -9.10% | |
| FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM) | Press release | Accesswire | -7.31% | -9.10% | |
| Form 6-K FSD Pharma Inc. For: Apr 22 | SEC filing · Form 6-K | SEC EDGAR | -5.60% | -7.74% | |
| FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) | Press release | Accesswire | -5.60% | -7.74% | |
| Form 6-K FSD Pharma Inc. For: Apr 16 | SEC filing · Form 6-K | SEC EDGAR | -2.51% | -7.34% | |
| FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products | Press release | Accesswire | -2.51% | -7.34% | |
| Form 6-K FSD Pharma Inc. For: Mar 29 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -0.60% | |
| Form 6-K FSD Pharma Inc. For: Apr 15 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -8.90% | |
| FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption | Press release | Accesswire | +0.00% | -8.90% | |
| Form 6-K FSD Pharma Inc. For: Apr 07 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +1.67% | |
| Form 20-F FSD Pharma Inc. For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | +4.01% | -0.45% | |
| FSD Pharma Announces Filing of Year-End 2023 Results | Press release | Accesswire | +4.01% | -0.45% | |
| Form 6-K FSD Pharma Inc. For: Mar 26 | SEC filing · Form 6-K | SEC EDGAR | +1.83% | +5.03% | |
| FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults | Press release | Accesswire | +1.83% | +5.03% | |
| Form 6-K FSD Pharma Inc. For: Mar 08 | SEC filing · Form 6-K | SEC EDGAR | -2.44% | -4.74% | |
| FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM) | Press release | Accesswire | -2.44% | -4.74% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the HUGE section they belong to.
Where else HUGE is measured.
HUGE earnings → · Analyst actions → · SEC filings →
Other Technology names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Tecsys Inc (TCS_TSE) | 112 | -0.52% | 9% |
| PagSeguro Digital Ltd. Class A Common Shares (PAGS) | 111 | -0.20% | 44% |
| SOLITRON DEVICES INC (SODI) | 110 | 0.00% | 20% |
| Weibo Corporation - American Depositary Shares (WB) | 110 | -0.24% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Technology names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is FSD Pharma Inc. - Class B Subordinate Voting Shares's median reaction calculated?
Every labeled HUGE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 110 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 44% of HUGE's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does HUGE's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.